GREY:BIOAF - Post by User
Comment by
Boomskidon May 31, 2023 9:14pm
134 Views
Post# 35473996
RE:Biodexa
RE:BiodexaNah, don't agree, poof. I think the whole deal was about the xB3 Platform. Biodexa would have received something for xB3 such as cancellation of the prepaid warrants and then a well-priced financing, based on far less dilution, etc, etc. Biodexa would maybe have kept xB3-licensed drugs for Hunter syndrome, the EGF stuff, maybe the deals with J&J and others.
But the meat would likely have gone to Armistice, or a vehicle supported/owned by the LG placees. If that had happened then Bioasis shareholders may have ultimately had a greater piece of Biodexa (with the pre-paid warrants gone) and then they could have ridden Biodexa to a win of some sort.
But without the xB3 platform. Midatech said that they (as Biodexa) would no longer be a drug delivery company. The big money would be made in private hands with brain tumours, inflammation (maybe), and other neurodegeneration therapeutics.
It can still happen. Bioasis shareholders can still get double digit ownership of Biodexa, but without the xB3 Platform.
I know. I'm repeating myself. And it's all speculation. It's kind of like the entire stock market, isn't it?
jd